Associations between inflammatory markers and common cancers
Inflammatory markers* . | HR*,† (95% CI) Number of events . | . | . | . | |||
---|---|---|---|---|---|---|---|
. | Breast . | Colorectal . | Lung . | Prostate . | |||
log(IL-6), pg/mL | 0.95 (0.54-1.65) 30 | 1.44 (0.90-2.31) 40 | 1.43 (0.91-2.26) 42 | 0.88 (0.59-1.30) 63 | |||
log(CRP), mg/L | 1.32 (0.91-1.93) 33 | 1.44 (1.03-2.02) 41 | 1.64 (1.20-2.24) 42 | 0.94 (0.70-1.28) 59 | |||
log(TNF-α), pg/mL | 0.70 (0.29-1.72) 31 | 0.90 (0.42-1.94) 39 | 1.67 (0.79-3.55) 39 | 1.10 (0.61-1.98) 64 |
Inflammatory markers* . | HR*,† (95% CI) Number of events . | . | . | . | |||
---|---|---|---|---|---|---|---|
. | Breast . | Colorectal . | Lung . | Prostate . | |||
log(IL-6), pg/mL | 0.95 (0.54-1.65) 30 | 1.44 (0.90-2.31) 40 | 1.43 (0.91-2.26) 42 | 0.88 (0.59-1.30) 63 | |||
log(CRP), mg/L | 1.32 (0.91-1.93) 33 | 1.44 (1.03-2.02) 41 | 1.64 (1.20-2.24) 42 | 0.94 (0.70-1.28) 59 | |||
log(TNF-α), pg/mL | 0.70 (0.29-1.72) 31 | 0.90 (0.42-1.94) 39 | 1.67 (0.79-3.55) 39 | 1.10 (0.61-1.98) 64 |